OBJECTIVE: To analyze extent and patterns of lung involvement in patients with idiopathic
pneumonia syndrome (IPS) following allogeneic stem cell transplantation (SCT), and …

Idiopathic pneumonia syndrome (IPS) is an acute lung dysfunction of non-infectious
aetiology and a severe complication following haematopoietic stem cell transplantation …

Our current knowledge of idiopathic pneumonia syndrome (IPS) predates improved
specificity in the diagnosis of IPS and advances in hematopoietic cell transplantation (HCT) …

Idiopathic pneumonia syndrome (IPS) is a noninfectious pulmonary complication of
allogeneic hematopoietic stem cell transplantation (AHSCT), which usually develops within …

PURPOSE: To determine the pathological correlation with various high-resolution CT
(HRCT) findings in cases with nonspecific interstitial pneumonia (NSIP), paying special …

Idiopathic pneumonia syndrome (IPS) is a rare complication following stem cell transplant
(SCT) and its incidence among pediatric SCT recipients is not known. To assess the …

Abstract Idiopathic Pneumonia Syndrome (IPS) is a common complication after allo-SCT
and results in high mortality rates. Conventional treatment for IPS typically includes …

Idiopathic pneumonia syndrome (IPS) is a complication of allogeneic hematopoietic stem
cell transplantation (HSCT) that typically occurs within the first 100 days after transplantation …

Idiopathic pneumonia syndrome (IPS) is a serious complication after hematopoietic stem cell
transplantation. Despite the high mortality rate with medical management, there have been …

We retrospectively analyzed 23 cases with early‐onset idiopathic pneumonia syndrome
(IPS) of 192 patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT) …